Fuji Corporation (TYO:6134)
2,839.50
+17.50 (0.62%)
Jul 31, 2025, 3:30 PM JST
CTI BioPharma Revenue
In the fiscal year ending March 31, 2025, Fuji Corporation had annual revenue of 127.39B JPY with 0.26% growth. Fuji Corporation had revenue of 33.82B in the quarter ending March 31, 2025, with 7.74% growth.
Revenue
127.39B
Revenue Growth
+0.26%
P/S Ratio
1.96
Revenue / Employee
42.80M
Employees
2,976
Market Cap
249.56B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 127.39B | 328.00M | 0.26% |
Mar 31, 2024 | 127.06B | -26.27B | -17.13% |
Mar 31, 2023 | 153.33B | 5.20B | 3.51% |
Mar 31, 2022 | 148.13B | 11.97B | 8.79% |
Mar 31, 2021 | 136.16B | -4.81B | -3.41% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Hitachi | 9,783.37B |
Recruit Holdings | 3,557.48B |
Mitsubishi Heavy Industries | 5,027.18B |
Mitsubishi | 18.62T |
ITOCHU | 14.72T |
Mitsui & | 14.66T |
Mitsubishi Electric | 5,521.71B |
Daikin Industries,Ltd. | 4,752.34B |